Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells

BACKGROUND: Mesenchymal stem cells (MSCs) have been utilized in treating acute graft-versus-host disease (aGvHD) as they show strong immunosuppressive capacity through the release of various mediators, including immunosuppressive molecules, growth factors, chemokines, and exosomes. MicroRNAs (miRNAs...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stem Cell Res Ther
Asıl Yazarlar: Liu, Weijiang, Zhou, Na, Liu, Yuanlin, Zhang, Wei, Li, Xue, Wang, Yang, Zheng, Rongxiu, Zhang, Yi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913292/
https://ncbi.nlm.nih.gov/pubmed/33637123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02159-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller